The Group's principal activity is to provide drug discovery and development services and products to pharmaceutical, biotechnology and medical device companies. The Group operates in two segments. The Development Sciences segment provides preclinical programs and clinical development services. The Discovery Sciences segment consists of functional genomics, which is the study of gene functions to identify drug targets within the body. This segment also provides biological chemistry research and preclinical biology services. It offers post-market support services for drugs receiving approval for market use. These services include product launch services, patient compliance programs and medical communications programs for consumer and healthcare providers on product use and adverse events.
Alacra Alerts:
Receive alerts on the latest reports on Pharmaceutical Product Development, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
